Order Article Reprints

Moura DS, Sanchez-Bustos P, Fernandez-Serra A, Lopez-Alvarez M, Mondaza-Hernandez JL, Blanco-Alcaina E, Gavilan-Naranjo A, Martinez-Delgado P, Lacerenza S, Santos-Fernandez P, et al. CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study. Cancers. 2020; 12(5):1128. https://doi.org/10.3390/cancers12051128

Moura, David S., Paloma Sanchez-Bustos, Antonio Fernandez-Serra, María Lopez-Alvarez, José L. Mondaza-Hernandez, Elena Blanco-Alcaina, Angela Gavilan-Naranjo, Paula Martinez-Delgado, Serena Lacerenza, Paloma Santos-Fernandez, and et al. 2020. "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" Cancers 12, no. 5: 1128. https://doi.org/10.3390/cancers12051128

Moura, D. S., Sanchez-Bustos, P., Fernandez-Serra, A., Lopez-Alvarez, M., Mondaza-Hernandez, J. L., Blanco-Alcaina, E., Gavilan-Naranjo, A., Martinez-Delgado, P., Lacerenza, S., Santos-Fernandez, P., Carrasco-Garcia, I., Hidalgo-Rios, S., Gutierrez, A., Ramos, R., Hindi, N., Taron, M., Lopez-Guerrero, J. A., & Martin-Broto, J. (2020). CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study. Cancers, 12(5), 1128. https://doi.org/10.3390/cancers12051128